Clinical Edge Journal Scan

Clinical Edge Journal Scan

CEBPA bZIP domain mutation holds prognostic relevance in de novo AML

Publish date: September 26, 2021

Read More

Clinical Edge Journal Scan

Oral azacitidine maintenance has manageable safety profile in AML patients in first CR/CRi

Publish date: September 26, 2021

Read More

Clinical Edge Journal Scan

Low-dose cytarabine+cladribine improves outcomes in elderly AML patients unfit for intensive chemotherapy

Publish date: September 26, 2021

Read More

Clinical Edge Journal Scan

GO vs. non-GO therapy offers better survival but with higher toxicity in AML and high-risk MDS

Publish date: September 26, 2021

Read More

Clinical Edge Journal Scan

Enasidenib vs. standard of care therapies prolongs survival in patients with R/R AML with IDH2 mutation

Publish date: September 26, 2021

Read More

Clinical Edge Journal Scan

No benefits of decitabine+sapacitabine over decitabine monotherapy in older patients with newly diagnosed AML

Publish date: September 26, 2021

Read More

Clinical Edge Journal Scan

Ramucirumab without antihistamine premedication may be feasible in advanced CRC

Publish date: September 18, 2021

Read More

Clinical Edge Journal Scan

Similar long-term outcomes after colorectal surgery in ulcerative colitis-associated vs. sporadic CRC

Publish date: September 18, 2021

Read More

Clinical Edge Journal Scan

SOX+bevacizumab or cetuximab combo offers similar benefits in recurrent advanced CRC

Publish date: September 18, 2021

Read More

Clinical Edge Journal Scan

CRC: COVID-19 lockdown-associated diagnostic delays tied to worse outcomes

Publish date: September 18, 2021

Read More

Clinical Edge Journal Scan

High fasting blood glucose tied to increased CRC risk in patients without diabetes

Publish date: September 18, 2021

Read More

Pages